GC
Gavin Clark-Gartner Evercore ISI Group Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
14
Avg Return
Past Year
Past Year
12%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $36 |
97%
upside
| 1 | -5.2% |
0
%
| 15 Dec ‘25 24 days ago |
|
|
|
Outperform
Maintained
| $94 |
15%
upside
| 2 | +17% |
0
%
| 9 Dec ‘25 1 month ago |
|
|
|
Outperform
Maintained
| $97 |
103%
upside
| 1 | +6.2% |
0
%
| 8 Dec ‘25 1 month ago |
|
|
|
Outperform
Initiated
| $40 |
119%
upside
| 1 | -12% |
0
%
| 1 Dec ‘25 1 month ago |
|
|
|
Outperform
Initiated
| $65 |
169%
upside
| 1 | +27% |
0
%
| 25 Nov ‘25 1 month ago |
|
|
|
Outperform
Maintained
| $910 |
14%
upside
| 1 | -3% |
0
%
| 31 Oct ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $14 |
743%
upside
| 2 | -26% |
0
%
| 22 Sep ‘25 3 months ago |
|
|
|
Outperform
Maintained
| $222 |
1%
downside
| 3 | +6.7% |
0
%
| 22 Sep ‘25 3 months ago |
|
|
|
Outperform
Initiated
| $5 |
138%
upside
| 1 | +36% |
0
%
| 29 Apr ‘25 8 months ago |
|
|
|
Outperform
Initiated
| $23 |
56%
upside
| 1 | +113% |
0
%
| 28 Jan ‘25 11 months ago |
|